Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.74 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 43.84.
Market Cap
8.74T
Revenue
4.59T
Profits
199.39B
PE Ratio
43.84
Profit Margin
4.34%
Dividend Yield
0.41%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | 0.93% | 2,758,787 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 589.48B | 1.61% | 10,134,113 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 429.58B | 3.51% | 10,281,744 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 377.36B | 2.40% | 4,498,026 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 309.84B | 4.02% | 14,049,340 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 288.22B | 1.45% | 1,826,302 | 60.44B |
| 7 | NVS | Novartis AG | 284.99B | 1.31% | 3,943,144 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.99B | 0.49% | 12,493,633 | 50.57B |
| 9 | AMGN | Amgen Inc. | 190.42B | 0.40% | 2,341,790 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 187.95B | 2.75% | 2,975,487 | 45.20B |
| 11 | ABT | Abbott Laboratories | 162.41B | 3.04% | 16,708,693 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 153.76B | -1.05% | 7,249,776 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 141.56B | -0.53% | 2,820,906 | 10.58B |
| 14 | DHR | Danaher Corporation | 136.75B | 2.30% | 4,983,974 | 24.78B |
| 15 | PFE | Pfizer Inc. | 134.91B | -1.54% | 57,956,981 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.54B | 2.74% | 8,920,210 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 121.87B | 1.05% | 1,522,551 | 12.22B |
| 18 | SYK | Stryker Corporation | 121.18B | 0.77% | 2,299,753 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 113.11B | 0.71% | 15,981,422 | 48.48B |
| 20 | GSK | GSK plc | 104.44B | 1.57% | 3,081,574 | 43.29B |
| 21 | MDT | Medtronic plc | 103.07B | 0.49% | 9,054,017 | 36.36B |
| 22 | SNY | Sanofi | 100.78B | 1.14% | 4,522,777 | 54.60B |
| 23 | MCK | McKesson Corporation | 89.43B | -0.36% | 1,186,644 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 85.84B | -0.21% | 1,145,965 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.11B | 0.86% | 1,284,626 | 200.42B |
| 26 | CI | The Cigna Group | 74.56B | 0.86% | 1,264,261 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 65.70B | -0.58% | 19,824,134 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.09B | -0.53% | 696,826 | 14.92B |
| 29 | COR | Cencora, Inc. | 55.83B | 0.87% | 1,486,274 | 328.68B |
| 30 | ARGX | argenx SE | 55.35B | 4.24% | 531,719 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 54.98B | 0.75% | 2,074,114 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.66B | 0.07% | 4,318,766 | 6.30B |
| 33 | MDLN | Medline Inc. | 49.62B | 4.77% | 8,819,220 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 49.40B | -0.45% | 2,865,936 | 28.34B |
| 35 | HUM | Humana Inc. | 45.14B | 3.97% | 1,151,131 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.78B | 1.05% | 628,901 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 41.71B | 2.44% | 2,548,950 | 22.23B |
| 38 | HLN | Haleon plc | 40.57B | 0.43% | 7,285,290 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.15B | -1.75% | 7,447,803 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.14B | -0.30% | 1,128,190 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 38.27B | 2.95% | 2,026,931 | 7.23B |
| 42 | RVMD | Revolution Medicines, Inc. | 37.88B | 4.95% | 4,991,567 | - |
| 43 | NTRA | Natera, Inc. | 37.34B | 0.30% | 2,466,538 | 2.50B |
| 44 | WAT | Waters Corporation | 37.01B | 2.09% | 936,590 | 3.77B |
| 45 | ALC | Alcon Inc. | 33.59B | 0.29% | 1,438,330 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 32.62B | -0.45% | 5,790,409 | 9.53B |
| 47 | CNC | Centene Corporation | 31.98B | 2.86% | 5,803,947 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 31.49B | 0.76% | 2,461,084 | 2.44B |
| 49 | IQV | IQVIA Holdings Inc. | 31.12B | 0.44% | 1,603,059 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 30.61B | -0.64% | 231,752 | 5.70B |
| 51 | BIIB | Biogen Inc. | 29.82B | 1.19% | 1,328,892 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.54B | 0.09% | 4,483,550 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.68B | 1.07% | 1,825,032 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 26.88B | 1.46% | 2,913,070 | 4.39B |
| 55 | DXCM | DexCom, Inc. | 26.49B | -1.58% | 3,405,825 | 4.82B |
| 56 | PHG | Koninklijke Philips N.V. | 25.94B | 2.10% | 848,386 | 20.34B |
| 57 | VEEV | Veeva Systems Inc. | 25.68B | -2.03% | 1,690,600 | 3.32B |
| 58 | MTD | Mettler-Toledo International Inc. | 25.13B | 3.34% | 399,346 | 4.09B |
| 59 | WST | West Pharmaceutical Services, Inc. | 24.48B | 1.81% | 1,615,321 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.47B | 0.03% | 9,801,133 | 8.26M |
| 61 | MRNA | Moderna, Inc. | 23.71B | -1.11% | 6,798,363 | 2.23B |
| 62 | UTHR | United Therapeutics Corporation | 23.07B | -1.18% | 285,355 | 3.17B |
| 63 | DGX | Quest Diagnostics Incorporated | 22.83B | 1.54% | 632,360 | 11.28B |
| 64 | BNTX | BioNTech SE | 22.76B | -0.23% | 701,956 | 3.23B |
| 65 | INSM | Insmed Incorporated | 22.64B | 0.98% | 3,551,152 | 819.56M |
| 66 | LH | Labcorp Holdings Inc. | 21.84B | 0.44% | 582,307 | 14.14B |
| 67 | INCY | Incyte Corporation | 21.48B | -0.86% | 1,435,018 | 5.36B |
| 68 | STE | STERIS plc | 20.52B | 1.66% | 837,061 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 18.95B | 4.37% | 2,547,270 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.71B | 0.88% | 8,364,043 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.60B | 0.44% | 1,189,682 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.51B | -1.13% | 783,662 | 3.10B |
| 73 | ASND | Ascendis Pharma A/S | 16.25B | 9.90% | 2,653,940 | 998.25M |
| 74 | GMAB | Genmab A/S | 16.10B | 1.06% | 1,279,854 | 3.90B |
| 75 | THC | Tenet Healthcare Corporation | 15.84B | 0.54% | 682,851 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 14.85B | 1.40% | 400,881 | 2.68B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 14.52B | 3.09% | 3,040,763 | 13.65B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 14.19B | -1.59% | 709,245 | 4.44B |
| 79 | COO | The Cooper Companies, Inc. | 13.78B | 2.63% | 3,267,092 | 4.23B |
| 80 | DVA | DaVita Inc. | 13.70B | 0.15% | 885,876 | 13.84B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 13.65B | 0.48% | 2,775,886 | 579.96M |
| 82 | SOLV | Solventum Corporation | 13.49B | 3.08% | 1,012,539 | 8.26B |
| 83 | EXEL | Exelixis, Inc. | 13.38B | 0.68% | 2,183,219 | 2.38B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.95B | 2.38% | 2,583,505 | 1.06B |
| 85 | SNN | Smith & Nephew plc | 12.85B | -0.13% | 1,269,865 | 6.16B |
| 86 | RVTY | Revvity, Inc. | 12.67B | 7.48% | 1,899,411 | 2.90B |
| 87 | ALGN | Align Technology, Inc. | 12.58B | 2.81% | 850,469 | 4.10B |
| 88 | FMS | Fresenius Medical Care AG | 12.50B | -2.52% | 782,394 | 22.32B |
| 89 | PEN | Penumbra, Inc. | 12.48B | 0.33% | 622,888 | 1.45B |
| 90 | ICLR | ICON Public Limited Company | 12.33B | 1.76% | 2,250,834 | 8.27B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 12.21B | -0.25% | 1,384,206 | 708.24M |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.17B | 1.71% | 3,059,112 | 4.89B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.91B | 4.02% | 4,308,089 | 3.58B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.85B | 0.79% | 362,447 | 1.13B |
| 95 | GMED | Globus Medical, Inc. | 11.49B | 3.08% | 1,898,671 | 3.10B |
| 96 | MOH | Molina Healthcare, Inc. | 11.25B | 7.26% | 1,801,385 | 43.10B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.17B | -0.68% | 2,429,904 | 622.01M |
| 98 | BAX | Baxter International Inc. | 11.13B | 2.42% | 5,563,922 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.08B | 0.03% | 1,127,876 | 3.24B |
| 100 | TECH | Bio-Techne Corporation | 11.07B | 20.08% | 51,553,625 | 1.21B |
| 101 | SMMT | Summit Therapeutics Inc. | 11.01B | -0.49% | 3,771,270 | - |
| 102 | CYTK | Cytokinetics, Incorporated | 10.97B | -0.49% | 2,386,626 | 105.82M |
| 103 | PODD | Insulet Corporation | 10.65B | 3.32% | 2,008,190 | 2.90B |
| 104 | KRYS | Krystal Biotech, Inc. | 10.61B | 3.54% | 329,750 | 417.30M |
| 105 | CRL | Charles River Laboratories International, Inc. | 10.25B | 5.25% | 1,536,058 | 4.03B |
| 106 | APGE | Apogee Therapeutics, Inc. | 9.94B | -0.01% | 4,819,160 | - |
| 107 | EHC | Encompass Health Corporation | 9.89B | -2.47% | 2,217,707 | 6.07B |
| 108 | TEM | Tempus AI, Inc. | 9.85B | 5.64% | 8,699,135 | 1.36B |
| 109 | NUVL | Nuvalent, Inc. | 9.76B | -0.04% | 1,179,225 | - |
| 110 | ENSG | The Ensign Group, Inc. | 9.61B | 1.02% | 934,968 | 5.27B |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.58B | 16.61% | 3,915,928 | 51.48M |
| 112 | HSIC | Henry Schein, Inc. | 9.53B | 1.05% | 1,028,328 | 13.38B |
| 113 | BRKR | Bruker Corporation | 9.27B | 4.19% | 2,794,105 | 3.46B |
| 114 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | 6.12% | 859,434 | 7.46M |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.10B | 3.91% | 1,102,943 | 769.10M |
| 116 | ALKS | Alkermes plc | 8.81B | 4.72% | 2,850,642 | 1.56B |
| 117 | UHS | Universal Health Services, Inc. | 8.75B | -0.65% | 762,026 | 17.76B |
| 118 | OSCR | Oscar Health, Inc. | 8.63B | -1.68% | 5,615,096 | 13.30B |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.62B | 2.09% | 1,455,698 | 1.51B |
| 120 | GKOS | Glaukos Corporation | 8.37B | 3.49% | 787,691 | 551.35M |
| 121 | RGEN | Repligen Corporation | 8.19B | 4.93% | 1,948,975 | 763.34M |
| 122 | IBRX | ImmunityBio, Inc. | 8.16B | -0.13% | 9,418,897 | 140.98M |
| 123 | ATR | AptarGroup, Inc. | 8.07B | 1.73% | 363,518 | 3.87B |
| 124 | QGEN | Qiagen N.V. | 8.05B | 0.54% | 3,487,890 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 7.98B | 6.51% | 591,755 | 2.59B |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 7.89B | 0.39% | 1,040,202 | 74.06M |
| 127 | IMVT | Immunovant, Inc. | 7.84B | -0.05% | 2,153,554 | - |
| 128 | PCVX | Vaxcyte, Inc. | 7.75B | -0.35% | 2,027,535 | - |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.70B | 2.82% | 1,864,914 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.60B | 0.06% | 2,601,596 | 700.35M |
| 131 | HIMS | Hims & Hers Health, Inc. | 7.57B | 0.03% | 13,884,519 | 2.37B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.42B | 0.66% | 690,625 | 217.17M |
| 133 | ABVX | ABIVAX Société Anonyme | 7.30B | -0.15% | 1,720,973 | 5.67M |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 7.15B | 2.01% | 1,624,434 | 569.61M |
| 135 | LNTH | Lantheus Holdings, Inc. | 7.10B | 3.97% | 1,298,120 | 1.55B |
| 136 | PTCT | PTC Therapeutics, Inc. | 7.01B | 0.12% | 1,986,539 | 827.11M |
| 137 | HQY | HealthEquity, Inc. | 6.97B | -1.85% | 715,133 | 1.34B |
| 138 | AVTR | Avantor, Inc. | 6.88B | 4.02% | 9,120,917 | 6.55B |
| 139 | LQDA | Liquidia Corporation | 6.84B | 1.83% | 1,572,857 | 288.07M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.50B | 1.27% | 3,270,040 | - |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.45B | 2.79% | 2,130,568 | - |
| 142 | PACS | PACS Group, Inc. | 6.44B | 4.71% | 1,133,944 | 5.43B |
| 143 | CGON | CG Oncology, Inc. | 6.42B | 6.00% | 1,359,655 | 5.07M |
| 144 | GRFS | Grifols, S.A. | 6.27B | 2.08% | 546,689 | 8.58B |
| 145 | TWST | Twist Bioscience Corporation | 6.02B | 5.80% | 2,784,640 | 409.48M |
| 146 | CHE | Chemed Corporation | 5.99B | 1.31% | 174,504 | 2.54B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.93B | 3.86% | 727,186 | 274.48M |
| 148 | BLTE | Belite Bio, Inc | 5.89B | -0.62% | 270,703 | - |
| 149 | HNGE | Hinge Health, Inc. | 5.81B | 6.49% | 2,505,374 | 646.34M |
| 150 | BLCO | Bausch + Lomb Corporation | 5.67B | 2.58% | 300,866 | 5.21B |
| 151 | TFX | Teleflex Incorporated | 5.66B | 1.01% | 310,304 | 2.13B |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.53B | 0.29% | 1,903,722 | 3.05B |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.49B | 2.32% | 2,814,173 | 536.20M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.49B | 2.16% | 1,115,988 | 7.50M |
| 155 | CAI | Caris Life Sciences, Inc. | 5.29B | 3.03% | 3,670,679 | 907.29M |
| 156 | LEGN | Legend Biotech Corporation | 5.28B | -3.23% | 2,631,259 | 1.14B |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.22B | 5.53% | 1,806,259 | - |
| 158 | CRSP | CRISPR Therapeutics AG | 5.21B | 0.80% | 2,092,279 | 4.10M |
| 159 | BLLN | BillionToOne, Inc. | 5.16B | 4.18% | 838,530 | 354.54M |
| 160 | INDV | Indivior Pharmaceuticals, Inc. | 5.03B | -0.43% | 1,667,987 | 1.29B |
| 161 | STVN | Stevanato Group S.p.A. | 5.02B | 6.67% | 243,187 | 1.39B |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 5.01B | 0.85% | 1,535,909 | 1.34M |
| 163 | MANE | Veradermics, Incorporated | 4.99B | 1.77% | 1,014,512 | - |
| 164 | DFTX | Definium Therapeutics, Inc. | 4.89B | 6.31% | 6,818,751 | - |
| 165 | SHC | Sotera Health Company | 4.88B | 2.46% | 2,392,486 | 1.19B |
| 166 | RDNT | RadNet, Inc. | 4.72B | 3.18% | 838,748 | 2.14B |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.69B | 4.70% | 6,292,033 | 4.26B |
| 168 | CELC | Celcuity Inc. | 4.68B | -0.47% | 1,427,151 | - |
| 169 | VCYT | Veracyte, Inc. | 4.67B | 3.15% | 1,470,770 | 541.74M |
| 170 | ERAS | Erasca, Inc. | 4.65B | -0.66% | 6,132,662 | - |
| 171 | TXG | 10x Genomics, Inc. | 4.54B | 3.27% | 2,949,464 | 638.78M |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.49B | -1.44% | 834,554 | - |
| 173 | LIVN | LivaNova PLC | 4.45B | 1.38% | 652,150 | 1.43B |
| 174 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.38B | -3.79% | 681,693 | 754.05M |
| 175 | TNGX | Tango Therapeutics, Inc. | 4.36B | 3.50% | 4,545,836 | 56.99M |
| 176 | NVST | Envista Holdings Corporation | 4.34B | 2.30% | 2,047,484 | 2.81B |
| 177 | VKTX | Viking Therapeutics, Inc. | 4.29B | -2.32% | 3,887,825 | - |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.23B | 2.36% | 647,470 | 1.54B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 4.06B | 1.54% | 1,491,560 | 1.10B |
| 180 | MMED | MiniMed Group, Inc. | 3.99B | 0.64% | 653,121 | 3.10B |
| 181 | DNLI | Denali Therapeutics Inc. | 3.92B | -0.36% | 1,195,340 | - |
| 182 | RLAY | Relay Therapeutics, Inc. | 3.89B | -1.05% | 6,143,184 | 10.68M |
| 183 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 1,170,089 | 596.96M |
| 184 | LFST | LifeStance Health Group, Inc. | 3.83B | 2.38% | 3,343,576 | 1.49B |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.81B | 3.13% | 883,883 | 787.85M |
| 186 | RCUS | Arcus Biosciences, Inc. | 3.80B | 5.03% | 2,332,989 | 236.00M |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.79B | 1.61% | 743,950 | 2.23B |
| 188 | ICUI | ICU Medical, Inc. | 3.71B | 3.89% | 416,654 | 2.16B |
| 189 | RGC | Regencell Bioscience Holdings Limited | 3.71B | -12.50% | 417,209 | - |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.71B | -2.76% | 1,737,919 | 22.57M |
| 191 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | -3.29% | 1,449,836 | 18.07M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.68B | -0.37% | 107,480 | 803.79M |
| 193 | BKD | Brookdale Senior Living Inc. | 3.68B | 4.90% | 5,065,912 | 3.00B |
| 194 | WAY | Waystar Holding Corp. | 3.64B | -0.21% | 1,974,892 | 1.16B |
| 195 | DOCS | Doximity, Inc. | 3.63B | -4.70% | 3,499,178 | 644.86M |
| 196 | OGN | Organon & Co. | 3.54B | -0.07% | 1,294,888 | 6.16B |
| 197 | HAE | Haemonetics Corporation | 3.53B | 6.52% | 746,058 | 1.33B |
| 198 | GPCR | Structure Therapeutics Inc. | 3.43B | 0.19% | 926,500 | - |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.41B | 1.38% | 1,627,644 | - |
| 200 | BEAM | Beam Therapeutics Inc. | 3.38B | 0.09% | 2,157,872 | 164.01M |
| 201 | WRBY | Warby Parker Inc. | 3.37B | 2.42% | 2,673,793 | 890.57M |
| 202 | OPCH | Option Care Health, Inc. | 3.37B | -2.41% | 2,121,547 | 5.67B |
| 203 | PBLS | Parabilis Medicines, Inc. | 3.36B | -3.51% | 1,043,952 | - |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | -2.48% | 1,971,834 | 415.62M |
| 205 | ADPT | Adaptive Biotechnologies Corporation | 3.24B | 4.71% | 3,960,843 | 295.41M |
| 206 | ALMS | Alumis Inc. | 3.19B | 0.72% | 1,117,207 | 8.40M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 3.19B | 0.03% | 1,199,490 | 225.27M |
| 208 | ITGR | Integer Holdings Corporation | 3.16B | 1.90% | 261,890 | 1.86B |
| 209 | NHC | National HealthCare Corporation | 3.15B | -0.63% | 105,491 | 1.53B |
| 210 | QURE | uniQure N.V. | 3.10B | 0.51% | 2,426,877 | 18.09M |
| 211 | PRVA | Privia Health Group, Inc. | 3.09B | 0.08% | 803,262 | 2.25B |
| 212 | HTFL | HeartFlow, Inc. | 3.02B | 0.20% | 1,169,804 | 191.42M |
| 213 | ELVN | Enliven Therapeutics, Inc. | 2.99B | 2.83% | 2,767,596 | - |
| 214 | VERA | Vera Therapeutics, Inc. | 2.91B | 2.51% | 2,884,953 | - |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.87B | 0.48% | 1,906,272 | 670.00M |
| 216 | GRAL | GRAIL, Inc. | 2.86B | 3.08% | 605,380 | 156.12M |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | -4.13% | 510,853 | 535.08M |
| 218 | CLOV | Clover Health Investments, Corp. | 2.74B | - | 4,723,173 | 2.21B |
| 219 | TMDX | TransMedics Group, Inc. | 2.69B | 0.17% | 902,773 | 635.89M |
| 220 | IRON | Disc Medicine, Inc. | 2.68B | -0.30% | 872,605 | - |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -3.32% | 317,421 | - |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.68B | 0.92% | 1,143,621 | 865.00K |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.62B | 2.13% | 695,460 | 229.58M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.60B | -0.86% | 697,624 | 776.83M |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.56B | 2.74% | 3,596,747 | - |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.52B | -1.00% | 19,058,368 | 885.72M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.46B | 1.43% | 543,212 | 1.46B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.41B | 5.13% | 3,694,517 | 3.37B |
| 229 | MBX | MBX Biosciences, Inc. | 2.40B | 4.07% | 1,232,152 | - |
| 230 | AXGN | Axogen, Inc. | 2.37B | 4.63% | 1,613,158 | 238.11M |
| 231 | PHVS | Pharvaris N.V. | 2.33B | 0.03% | 496,188 | - |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.32B | 16.37% | 4,955,982 | 71.78M |
| 233 | BHVN | Biohaven Ltd. | 2.31B | 2.54% | 6,061,186 | - |
| 234 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | -5.75% | 2,151,286 | 298.30M |
| 235 | NTLA | Intellia Therapeutics, Inc. | 2.24B | 3.42% | 2,945,890 | 66.09M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | -0.30% | 415,122 | 1.09B |
| 237 | IMNM | Immunome, Inc. | 2.20B | -1.77% | 3,193,826 | 4.02M |
| 238 | VCEL | Vericel Corporation | 2.19B | 2.90% | 554,732 | 292.09M |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.17B | 2.19% | 946,318 | - |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.16B | 2.47% | 3,875,348 | 3.68B |
| 241 | ASTH | Astrana Health, Inc. | 2.16B | 2.91% | 523,158 | 3.53B |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.15B | -0.22% | 773,300 | 66.05M |
| 243 | LMAT | LeMaitre Vascular, Inc. | 2.15B | 1.85% | 306,357 | 256.28M |
| 244 | PGNY | Progyny, Inc. | 2.14B | 1.82% | 604,033 | 1.29B |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.14B | -0.91% | 2,238,639 | 52.04M |
| 246 | KOD | Kodiak Sciences Inc. | 2.13B | -5.31% | 1,028,850 | - |
| 247 | GENB | Generate Biomedicines, Inc. | 2.10B | 1.17% | 843,799 | 30.30M |
| 248 | BFLY | Butterfly Network, Inc. | 2.10B | 3.22% | 6,052,204 | 102.92M |
| 249 | NKTR | Nektar Therapeutics | 2.10B | -4.33% | 938,644 | 55.63M |
| 250 | ZLAB | Zai Lab Limited | 2.08B | 0.82% | 717,203 | 453.28M |
| 251 | NEOG | Neogen Corporation | 2.07B | 3.59% | 1,641,964 | 870.56M |
| 252 | SEM | Select Medical Holdings Corporation | 2.05B | -0.12% | 8,569,854 | 5.52B |
| 253 | WGS | GeneDx Holdings Corp. | 2.04B | 8.07% | 1,192,421 | 442.68M |
| 254 | ABCL | AbCellera Biologics Inc. | 2.03B | 10.45% | 11,335,006 | 79.21M |
| 255 | NUVB | Nuvation Bio Inc. | 2.02B | -10.06% | 22,432,540 | 143.05M |
| 256 | ADMA | ADMA Biologics, Inc. | 2.02B | 0.23% | 3,584,421 | 509.86M |
| 257 | KARD | Kardigan, Inc. | 2.02B | 2.50% | 299,470 | - |
| 258 | SGRY | Surgery Partners, Inc. | 2.00B | 1.61% | 1,150,389 | 3.34B |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.93% | 534,959 | 899.11M |
| 260 | BHC | Bausch Health Companies Inc. | 1.97B | 5.81% | 3,133,178 | 10.53B |
| 261 | PGEN | Precigen, Inc. | 1.97B | 2.22% | 5,354,575 | 31.60M |
| 262 | SLS | SELLAS Life Sciences Group, Inc. | 1.96B | 14.83% | 14,679,566 | - |
| 263 | PVLA | Palvella Therapeutics, Inc. | 1.96B | 4.99% | 277,799 | - |
| 264 | UFPT | UFP Technologies, Inc. | 1.95B | 3.96% | 195,294 | 608.85M |
| 265 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | 2.59% | 3,504,169 | -665.00K |
| 266 | MD | Pediatrix Medical Group, Inc. | 1.93B | -0.45% | 575,823 | 1.93B |
| 267 | SION | Sionna Therapeutics, Inc. | 1.93B | 4.09% | 475,583 | - |
| 268 | VRDN | Viridian Therapeutics, Inc. | 1.92B | 0.40% | 1,877,943 | 70.92M |
| 269 | PLSE | Pulse Biosciences, Inc. | 1.90B | 7.44% | 272,801 | 751.00K |
| 270 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.76% | 112,443 | 1.20B |
| 271 | STOK | Stoke Therapeutics, Inc. | 1.89B | 0.03% | 916,314 | 32.08M |
| 272 | IOVA | Iovance Biotherapeutics, Inc. | 1.88B | -0.94% | 8,329,123 | 285.61M |
| 273 | MESO | Mesoblast Limited | 1.86B | -6.75% | 332,826 | 65.38M |
| 274 | ALMR | Alamar Biosciences, Inc. | 1.86B | 12.76% | 513,788 | 87.16M |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.86B | -2.73% | 410,177 | 20.00M |
| 276 | AVAH | Aveanna Healthcare Holdings Inc. | 1.85B | 0.12% | 2,056,735 | 2.52B |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.84B | 1.56% | 634,165 | - |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.83B | 1.81% | 766,687 | 367.34M |
| 279 | CMPS | COMPASS Pathways plc | 1.83B | 7.95% | 3,176,162 | - |
| 280 | GLUE | Monte Rosa Therapeutics, Inc. | 1.83B | 3.88% | 1,439,149 | 42.95M |
| 281 | HCM | HUTCHMED (China) Limited | 1.80B | 0.19% | 49,970 | 548.51M |
| 282 | OMCL | Omnicell, Inc. | 1.80B | 0.10% | 766,620 | 1.23B |
| 283 | AGL | agilon health, inc. | 1.79B | 0.27% | 386,542 | 5.82B |
| 284 | NEO | NeoGenomics, Inc. | 1.79B | 6.43% | 4,310,718 | 745.97M |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.78B | -10.52% | 11,788,618 | 7.47M |
| 286 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | 3.41% | 14,549,646 | 66.41M |
| 287 | ADUS | Addus HomeCare Corporation | 1.77B | -0.35% | 166,945 | 1.45B |
| 288 | ANIP | ANI Pharmaceuticals, Inc. | 1.77B | 0.68% | 264,527 | 923.71M |
| 289 | CAPR | Capricor Therapeutics, Inc. | 1.76B | 3.02% | 1,028,799 | 11.13M |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.85% | 1,470,428 | 217.17M |
| 291 | NVCR | NovoCure Limited | 1.74B | 2.24% | 1,290,324 | 674.41M |
| 292 | GHRS | GH Research PLC | 1.74B | 3.01% | 171,035 | - |
| 293 | ANAB | AnaptysBio, Inc. | 1.74B | 2.05% | 302,217 | 232.39M |
| 294 | ZYME | Zymeworks Inc. | 1.74B | -2.18% | 429,767 | 81.26M |
| 295 | BCAX | Bicara Therapeutics Inc. | 1.73B | 2.73% | 1,216,612 | - |
| 296 | NBTX | Nanobiotix S.A. | 1.73B | -0.84% | 55,638 | 38.27M |
| 297 | INVA | Innoviva, Inc. | 1.72B | -1.23% | 605,581 | 420.69M |
| 298 | AKTS | Aktis Oncology, Inc. | 1.72B | 8.54% | 859,883 | 8.28M |
| 299 | SRPT | Sarepta Therapeutics, Inc. | 1.69B | -4.04% | 2,541,690 | 2.18B |
| 300 | ATAI | AtaiBeckley Inc. | 1.69B | 9.83% | 11,003,270 | 3.49M |
| 301 | FTRE | Fortrea Holdings Inc. | 1.68B | 4.05% | 1,918,159 | 2.71B |
| 302 | URGN | UroGen Pharma Ltd. | 1.68B | -2.94% | 414,605 | 140.49M |
| 303 | VIR | Vir Biotechnology, Inc. | 1.67B | -0.70% | 1,336,973 | 65.50M |
| 304 | TRLV | Trulieve Cannabis Corp. | 1.64B | 0.24% | 1,690,092 | 1.17B |
| 305 | HCSG | Healthcare Services Group, Inc. | 1.62B | 0.21% | 443,450 | 1.85B |
| 306 | ABSI | Absci Corporation | 1.59B | 1.34% | 13,221,529 | 1.84M |
| 307 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.58B | 6.25% | 6,474,061 | 204.73M |
| 308 | AVBP | ArriVent BioPharma, Inc. | 1.58B | 5.64% | 1,034,013 | - |
| 309 | ZBIO | Zenas BioPharma, Inc. | 1.56B | 13.17% | 1,590,529 | 10.00M |
| 310 | SEPN | Septerna, Inc. | 1.56B | -4.19% | 283,886 | 72.26M |
| 311 | IMCR | Immunocore Holdings plc | 1.55B | 1.93% | 827,001 | 412.81M |
| 312 | STAA | STAAR Surgical Company | 1.55B | 7.92% | 639,689 | 290.38M |
| 313 | HROW | Harrow, Inc. | 1.55B | -2.76% | 677,932 | 268.68M |
| 314 | SVRA | Savara Inc. | 1.53B | 3.43% | 2,633,238 | - |
| 315 | ARDX | Ardelyx, Inc. | 1.50B | -2.10% | 2,109,212 | 427.68M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.50B | 1.31% | 1,180,512 | 20.00M |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.47B | -0.05% | 1,513,946 | - |
| 318 | AAPG | Ascentage Pharma Group International | 1.46B | -0.18% | 7,372 | 82.08M |
| 319 | MPLT | MapLight Therapeutics, Inc. | 1.45B | 4.27% | 463,218 | - |
| 320 | CDNA | CareDx, Inc. | 1.44B | 2.65% | 1,315,834 | 412.82M |
| 321 | TDOC | Teladoc Health, Inc. | 1.43B | 1.28% | 3,219,315 | 2.51B |
| 322 | ATRC | AtriCure, Inc. | 1.42B | -0.53% | 1,038,810 | 552.16M |
| 323 | IART | Integra LifeSciences Holdings Corporation | 1.41B | 1.80% | 847,968 | 1.64B |
| 324 | NVAX | Novavax, Inc. | 1.41B | -3.82% | 4,360,747 | 596.34M |
| 325 | INNV | InnovAge Holding Corp. | 1.40B | 7.03% | 355,691 | 949.17M |
| 326 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 0.18% | 283,617 | 1.30M |
| 327 | DMRA | Damora Therapeutics, Inc. | 1.39B | 2.59% | 380,510 | - |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.36B | 1.49% | 2,276,163 | 787.08M |
| 329 | BLFS | BioLife Solutions, Inc. | 1.34B | 7.55% | 1,928,579 | 101.66M |
| 330 | ARDT | Ardent Health, Inc. | 1.34B | -0.43% | 604,271 | 6.43B |
| 331 | PRGO | Perrigo Company plc | 1.34B | -0.82% | 2,656,313 | 4.18B |
| 332 | AHCO | AdaptHealth Corp. | 1.33B | -0.10% | 2,068,920 | 3.29B |
| 333 | KMTS | Kestra Medical Technologies, Ltd. | 1.32B | 2.76% | 322,540 | 83.72M |
| 334 | PSNL | Personalis, Inc. | 1.32B | 10.83% | 5,262,113 | 64.52M |
| 335 | IMTX | Immatics N.V. | 1.30B | -4.94% | 289,820 | 43.00M |
| 336 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | -3.60% | 126,429 | - |
| 337 | JBIO | Jade Biosciences, Inc. | 1.29B | -0.41% | 826,479 | - |
| 338 | PAHC | Phibro Animal Health Corporation | 1.29B | 1.50% | 138,769 | 1.50B |
| 339 | AVLN | Avalyn Pharma Inc. | 1.28B | -3.69% | 279,420 | - |
| 340 | XERS | Xeris Biopharma Holdings, Inc. | 1.28B | - | 1,918,632 | 314.85M |
| 341 | ENOV | Enovis Corporation | 1.27B | 2.95% | 747,461 | 2.28B |
| 342 | AMN | AMN Healthcare Services, Inc. | 1.25B | 1.92% | 792,917 | 3.42B |
| 343 | INSP | Inspire Medical Systems, Inc. | 1.25B | 0.58% | 991,410 | 915.25M |
| 344 | PNTG | The Pennant Group, Inc. | 1.25B | 3.67% | 199,029 | 1.02B |
| 345 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | 3.07% | 1,738,560 | 322.02M |
| 346 | MNKD | MannKind Corporation | 1.21B | 2.34% | 3,234,569 | 360.78M |
| 347 | SDGR | Schrödinger, Inc. | 1.21B | 5.28% | 1,755,272 | 254.91M |
| 348 | IRMD | IRADIMED CORPORATION | 1.20B | -0.96% | 98,588 | 86.28M |
| 349 | AVNS | Avanos Medical, Inc. | 1.17B | -0.20% | 414,094 | 715.90M |
| 350 | ALVO | Alvotech | 1.17B | -5.95% | 1,088,260 | 562.04M |
| 351 | EYPT | EyePoint, Inc. | 1.15B | -4.79% | 1,249,691 | 7.61M |
| 352 | AHG | Akso Health Group | 1.15B | -0.74% | 1,525 | 14.84M |
| 353 | OPK | OPKO Health, Inc. | 1.14B | 1.34% | 1,891,034 | 581.12M |
| 354 | CGEM | Cullinan Therapeutics, Inc. | 1.14B | 4.70% | 1,303,874 | - |
| 355 | AZTA | Azenta, Inc. | 1.14B | 3.23% | 650,863 | 596.48M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -2.05% | 229,560 | 796.33M |
| 357 | OMDA | Omada Health, Inc. | 1.12B | 1.61% | 908,382 | 283.30M |
| 358 | WVE | Wave Life Sciences Ltd. | 1.11B | -3.36% | 3,224,393 | 71.80M |
| 359 | AORT | Artivion, Inc. | 1.10B | 2.86% | 1,008,816 | 458.69M |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 0.77% | 1,305,180 | - |
| 361 | XNCR | Xencor, Inc. | 1.09B | 2.01% | 874,724 | 97.36M |
| 362 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | 4.93% | 2,304,856 | 1.03B |
| 363 | MGTX | MeiraGTx Holdings plc | 1.07B | -0.60% | 774,163 | 79.76M |
| 364 | CNMD | CONMED Corporation | 1.04B | -2.37% | 290,478 | 1.37B |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.04B | 1.24% | 194,965 | - |
| 366 | NUTX | Nutex Health Inc. | 1.03B | 1.06% | 77,009 | 879.95M |
| 367 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 3.15% | 3,281,366 | 69.64M |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | 6.01% | 679,611 | 1.03B |
| 369 | CRON | Cronos Group Inc. | 1.02B | 0.74% | 884,072 | 159.54M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.01B | 0.17% | 221,650 | 787.69M |
| 371 | DRTS | Alpha Tau Medical Ltd. | 1.01B | 11.14% | 1,059,120 | - |
| 372 | BIOA | BioAge Labs, Inc. | 1.01B | -0.92% | 944,007 | 10.32M |
| 373 | OLMA | Olema Pharmaceuticals, Inc. | 998.38M | 2.60% | 2,565,136 | - |
| 374 | ORIC | ORIC Pharmaceuticals, Inc. | 979.28M | 0.32% | 1,646,575 | - |
| 375 | EVO | Evotec SE | 979.00M | 0.74% | 55,821 | 859.03M |
| 376 | SANA | Sana Biotechnology, Inc. | 977.67M | -0.61% | 2,853,082 | - |
| 377 | AVR | Anteris Technologies Global Corp. | 961.74M | -5.00% | 1,347,754 | 1.85M |
| 378 | PCRX | Pacira BioSciences, Inc. | 958.91M | 1.71% | 376,120 | 734.86M |
| 379 | ETON | Eton Pharmaceuticals, Inc. | 953.80M | 2.47% | 414,468 | 86.93M |
| 380 | DBVT | DBV Technologies S.A. | 950.00M | 2.69% | 716,384 | 5.74M |
| 381 | AVTX | Avalo Therapeutics, Inc. | 946.18M | -0.88% | 1,689,256 | 59.00K |
| 382 | PHAR | Pharming Group N.V. | 941.11M | 0.85% | 10,635 | 369.49M |
| 383 | INMD | InMode Ltd. | 938.34M | 0.14% | 1,272,409 | 374.64M |
| 384 | AMPH | Amphastar Pharmaceuticals, Inc. | 926.61M | -0.02% | 481,265 | 720.53M |
| 385 | QDEL | QuidelOrtho Corporation | 921.94M | 10.73% | 1,458,358 | 2.66B |
| 386 | KURA | Kura Oncology, Inc. | 919.70M | -2.45% | 1,232,564 | 71.64M |
| 387 | REPL | Replimune Group, Inc. | 919.03M | -1.24% | 1,933,000 | - |
| 388 | GDRX | GoodRx Holdings, Inc. | 911.04M | -2.54% | 745,641 | 787.89M |
| 389 | TBPH | Theravance Biopharma, Inc. | 896.51M | 0.69% | 310,536 | 109.78M |
| 390 | JANX | Janux Therapeutics, Inc. | 889.15M | -0.41% | 6,510,299 | 13.73M |
| 391 | LBRX | LB Pharmaceuticals Inc | 888.12M | 1.61% | 213,094 | - |
| 392 | ANRO | Alto Neuroscience, Inc. | 887.88M | 1.57% | 322,186 | - |
| 393 | GERN | Geron Corporation | 878.88M | -1.08% | 9,546,027 | 196.12M |
| 394 | SLDB | Solid Biosciences Inc. | 872.26M | -4.22% | 1,336,407 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 871.14M | -1.12% | 2,439,905 | 191.45M |
| 396 | TALK | Talkspace, Inc. | 869.39M | - | 2,242,049 | 238.37M |
| 397 | EVMN | Evommune, Inc. | 869.12M | 2.42% | 492,492 | 10.00M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 856.54M | -3.14% | 237,561 | 1.06M |
| 399 | CERT | Certara, Inc. | 854.05M | 1.10% | 2,952,248 | 419.75M |
| 400 | ANNX | Annexon, Inc. | 843.79M | -2.83% | 3,831,642 | - |
| 401 | DSGN | Design Therapeutics, Inc. | 839.42M | -2.47% | 630,024 | - |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 821.31M | -2.54% | 1,082,356 | 204.89M |
| 403 | BVS | Bioventus Inc. | 812.79M | 2.42% | 594,787 | 576.30M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 810.91M | - | 8,816,067 | 418.24M |
| 405 | VOR | Vor Biopharma Inc. | 809.00M | 3.11% | 903,602 | - |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 796.41M | -23.91% | 8,081,868 | 98.99M |
| 407 | GMRS | GMR Solutions Inc. | 791.27M | 7.80% | 850,553 | 5.83B |
| 408 | ZVRA | Zevra Therapeutics, Inc. | 782.09M | 1.15% | 973,071 | 122.29M |
| 409 | OMER | Omeros Corporation | 775.86M | 1.32% | 1,143,187 | 9.89M |
| 410 | AURA | Aura Biosciences, Inc. | 756.65M | -2.56% | 336,066 | - |
| 411 | HSTM | HealthStream, Inc. | 750.83M | -1.57% | 181,072 | 311.78M |
| 412 | CBLL | CeriBell, Inc. | 748.61M | 6.02% | 422,399 | 95.07M |
| 413 | SIBN | SI-BONE, Inc. | 743.29M | 2.57% | 418,259 | 206.22M |
| 414 | NVCT | Nuvectis Pharma, Inc. | 739.27M | 13.85% | 733,730 | - |
| 415 | CLYM | Climb Bio, Inc. | 724.92M | -0.71% | 1,103,499 | - |
| 416 | SSII | SS Innovations International, Inc. | 716.47M | 1.70% | 37,135 | 48.47M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 711.89M | -1.51% | 2,911,790 | 35.54M |
| 418 | ALLO | Allogene Therapeutics, Inc. | 711.02M | 0.49% | 9,354,153 | 22.00K |
| 419 | BBNX | Beta Bionics, Inc. | 708.98M | 8.01% | 1,093,074 | 110.24M |
| 420 | OCS | Oculis Holding AG | 708.96M | 1.56% | 500,455 | 1.40M |
| 421 | NNNN | Anbio Biotechnology | 706.65M | 5.57% | 199,160 | 8.65M |
| 422 | IVA | Inventiva S.A. | 703.47M | 1.16% | 2,121,073 | 7.94M |
| 423 | CSTL | Castle Biosciences, Inc. | 694.86M | 3.57% | 305,329 | 339.92M |
| 424 | CADL | Candel Therapeutics, Inc. | 693.87M | 2.16% | 1,144,472 | - |
| 425 | IMMX | Immix Biopharma, Inc. | 691.97M | -3.19% | 1,197,963 | - |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 685.75M | 2.51% | 1,329,302 | 8.37M |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 684.39M | 1.20% | 271,718 | 299.77M |
| 428 | SLBT | SL Science Holding Limited | 677.21M | 11.73% | 145,272 | - |
| 429 | RLMD | Relmada Therapeutics, Inc. | 676.54M | -0.92% | 2,398,842 | - |
| 430 | AGMB | AgomAb Therapeutics NV | 668.30M | 7.02% | 93,901 | - |
| 431 | DRUG | Bright Minds Biosciences Inc. | 660.55M | -3.90% | 152,421 | - |
| 432 | TENX | Tenax Therapeutics, Inc. | 658.57M | -0.31% | 683,785 | - |
| 433 | FTH | Faeth Therapeutics, Inc. | 635.96M | 0.53% | 83,586 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 632.12M | -1.79% | 1,659,093 | 361.51M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 631.58M | 1.86% | 132,034 | 343.52M |
| 436 | SGP | SpyGlass Pharma, Inc. | 627.54M | -3.99% | 109,831 | - |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 625.16M | -1.64% | 1,434,516 | 151.40M |
| 438 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 616.02M | 3.36% | 471,188 | - |
| 439 | CRMD | CorMedix Inc. | 605.65M | -7.99% | 3,042,317 | 400.05M |
| 440 | FDMT | 4D Molecular Therapeutics, Inc. | 602.22M | -0.86% | 985,299 | 88.24M |
| 441 | CTEV | Claritev Corporation | 591.90M | 13.87% | 102,927 | 978.76M |
| 442 | BWAY | BrainsWay Ltd. | 590.59M | 0.97% | 53,459 | 56.22M |
| 443 | TECX | Tectonic Therapeutic, Inc. | 585.51M | 1.01% | 79,987 | - |
| 444 | ACHV | Achieve Life Sciences, Inc. | 585.16M | 7.55% | 3,727,457 | - |
| 445 | MNPR | Monopar Therapeutics Inc. | 584.67M | -1.92% | 203,059 | - |
| 446 | CTKB | Cytek Biosciences, Inc. | 577.27M | 4.44% | 1,362,311 | 204.17M |
| 447 | PRME | Prime Medicine, Inc. | 574.36M | 1.92% | 2,833,858 | 4.03M |
| 448 | CERS | Cerus Corporation | 573.06M | 8.33% | 4,026,546 | 216.56M |
| 449 | TRAX | First Tracks Biotherapeutics, Inc. | 571.19M | -1.92% | 579,423 | - |
| 450 | ANGO | AngioDynamics, Inc. | 569.38M | 5.48% | 313,235 | 313.73M |
| 451 | GYRE | Gyre Therapeutics, Inc. | 569.25M | -3.86% | 73,360 | 117.05M |
| 452 | MDXG | MiMedx Group, Inc. | 567.48M | -0.52% | 922,341 | 389.42M |
| 453 | EVH | Evolent Health, Inc. | 565.78M | - | 1,792,011 | 1.89B |
| 454 | CBIO | Crescent Biopharma, Inc. | 564.56M | -2.13% | 181,924 | 11.88M |
| 455 | PHR | Phreesia, Inc. | 564.34M | -4.80% | 1,101,951 | 495.59M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 560.13M | -10.52% | 5,171,477 | 50.27M |
| 457 | ALT | Altimmune, Inc. | 558.14M | -2.71% | 2,781,981 | 36.00K |
| 458 | NPCE | NeuroPace, Inc. | 557.77M | 0.86% | 145,946 | 99.53M |
| 459 | FLGT | Fulgent Genetics, Inc. | 550.97M | 1.41% | 252,326 | 320.35M |
| 460 | CLPT | ClearPoint Neuro, Inc. | 538.61M | -0.11% | 585,609 | 40.61M |
| 461 | EIKN | Eikon Therapeutics, Inc. | 533.27M | 2.28% | 352,616 | - |
| 462 | TLRY | Tilray Brands, Inc. | 532.00M | -2.83% | 3,563,413 | 858.28M |
| 463 | RGNX | REGENXBIO Inc. | 529.38M | 2.71% | 1,550,278 | 87.82M |
| 464 | XOMA | XOMA Royalty Corporation | 529.23M | 0.12% | 122,047 | 48.56M |
| 465 | RZLT | Rezolute, Inc. | 525.47M | - | 1,262,093 | - |
| 466 | ARVN | Arvinas, Inc. | 518.11M | -0.25% | 396,128 | 89.40M |
| 467 | PROK | ProKidney Corp. | 513.50M | -3.95% | 1,045,090 | 889.00K |
| 468 | MYGN | Myriad Genetics, Inc. | 512.85M | 4.02% | 1,843,683 | 829.00M |
| 469 | TOI | The Oncology Institute, Inc. | 511.91M | -2.48% | 1,026,284 | 545.76M |
| 470 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 471 | KIDS | OrthoPediatrics Corp. | 503.94M | 2.51% | 148,164 | 243.30M |
| 472 | KYTX | Kyverna Therapeutics, Inc. | 498.52M | -4.87% | 1,536,588 | - |
| 473 | PACB | Pacific Biosciences of California, Inc. | 496.96M | 11.11% | 10,580,384 | 160.03M |
| 474 | CTNM | Contineum Therapeutics, Inc. | 496.86M | 3.67% | 349,810 | - |
| 475 | STRO | Sutro Biopharma, Inc. | 489.66M | -1.60% | 299,262 | 99.61M |
| 476 | CCCC | C4 Therapeutics, Inc. | 486.50M | 3.53% | 2,500,164 | 34.86M |
| 477 | PRTA | Prothena Corporation plc | 485.31M | -0.96% | 964,889 | 57.94M |
| 478 | ASMB | Assembly Biosciences, Inc. | 480.77M | -5.31% | 270,969 | 71.10M |
| 479 | NGNE | Neurogene Inc. | 480.54M | 1.13% | 157,635 | 925.00K |
| 480 | CABA | Cabaletta Bio, Inc. | 476.12M | -3.63% | 3,702,548 | - |
| 481 | VALN | Valneva SE | 474.76M | -0.38% | 52,118 | 180.25M |
| 482 | SLN | Silence Therapeutics plc | 472.34M | 9.17% | 1,307,477 | 839.00K |
| 483 | EOLS | Evolus, Inc. | 470.86M | 2.58% | 523,794 | 301.79M |
| 484 | SOPH | SOPHiA GENETICS SA | 468.38M | 3.08% | 363,999 | 81.18M |
| 485 | SRTA | Strata Critical Medical, Inc. | 463.78M | -2.72% | 915,204 | 228.58M |
| 486 | OCGN | Ocugen, Inc. | 463.77M | -1.44% | 5,378,357 | 4.47M |
| 487 | NRC | NRC Health | 462.90M | -0.77% | 72,901 | 138.64M |
| 488 | VTVT | vTv Therapeutics Inc. | 460.89M | 3.92% | 82,355 | 36.84M |
| 489 | FBRX | Forte Biosciences, Inc. | 457.19M | 0.92% | 186,507 | - |
| 490 | STTK | Shattuck Labs, Inc. | 453.18M | -1.66% | 1,276,958 | 1.00M |
| 491 | OVID | Ovid Therapeutics Inc. | 451.67M | -3.20% | 2,140,000 | 7.12M |
| 492 | VMD | Viemed Healthcare, Inc. | 448.16M | 1.92% | 519,094 | 286.57M |
| 493 | SI | Shoulder Innovations, Inc. | 448.15M | 9.31% | 180,705 | 53.89M |
| 494 | BNTC | Benitec Biopharma Inc. | 446.61M | -4.77% | 181,880 | - |
| 495 | VREX | Varex Imaging Corporation | 433.69M | -0.77% | 290,616 | 857.50M |
| 496 | WEAV | Weave Communications, Inc. | 433.63M | 0.37% | 806,700 | 248.72M |
| 497 | CYH | Community Health Systems, Inc. | 433.45M | 1.27% | 780,508 | 12.29B |
| 498 | MOBI | Mobia Medical, Inc. | 432.57M | 0.23% | 133,270 | 38.45M |
| 499 | ZURA | Zura Bio Limited | 431.29M | 6.57% | 1,289,001 | - |
| 500 | ARTV | Artiva Biotherapeutics, Inc. | 429.03M | -5.26% | 512,915 | 251.00K |